Displaying 13 - 24 of 51
Metabolism, Alcohol & Toxicity
6

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025

View
Metabolism, Alcohol & Toxicity
6

Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
1

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: "Global Liver Health Forum 2023" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: "Global Liver Health Forum 2023" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: "Global Liver Health Forum 2023" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: "Global Liver Health Forum 2023" - EASL Congress 2023

View
Displaying 13 - 24 of 51